Stockman Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-427
| Closed | -$222K | – | 174 |
|
2024
Q4 | $222K | Hold |
427
| – | – | 0.03% | 150 |
|
2024
Q3 | $264K | Sell |
427
-3
| -0.7% | -$1.86K | 0.04% | 151 |
|
2024
Q2 | $238K | Sell |
430
-50
| -10% | -$27.7K | 0.04% | 153 |
|
2024
Q1 | $279K | Sell |
480
-12
| -2% | -$6.98K | 0.05% | 147 |
|
2023
Q4 | $261K | Sell |
492
-18
| -4% | -$9.55K | 0.05% | 145 |
|
2023
Q3 | $258K | Buy |
510
+18
| +4% | +$9.11K | 0.06% | 151 |
|
2023
Q2 | $257K | Sell |
492
-2
| -0.4% | -$1.04K | 0.06% | 163 |
|
2023
Q1 | $285K | Sell |
494
-23
| -4% | -$13.3K | 0.06% | 163 |
|
2022
Q4 | $285K | Sell |
517
-13
| -2% | -$7.16K | 0.07% | 153 |
|
2022
Q3 | $269K | Sell |
530
-15
| -3% | -$7.61K | 0.07% | 149 |
|
2022
Q2 | $296K | Hold |
545
| – | – | 0.08% | 141 |
|
2022
Q1 | $322K | Buy |
545
+105
| +24% | +$62K | 0.07% | 153 |
|
2021
Q4 | $294K | Sell |
440
-12
| -3% | -$8.02K | 0.06% | 161 |
|
2021
Q3 | $258K | Sell |
452
-90
| -17% | -$51.4K | 0.06% | 172 |
|
2021
Q2 | $273K | Buy |
542
+90
| +20% | +$45.3K | 0.07% | 160 |
|
2021
Q1 | $206K | Sell |
452
-106
| -19% | -$48.3K | 0.06% | 177 |
|
2020
Q4 | $260K | Buy |
+558
| New | +$260K | 0.08% | 150 |
|